Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.535 Million Tokens, and Total Crypto... (PR Newswire) +++ BITMINE IMMERSION Aktie +3,09%

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
09.03.26 - 13:51
KommuneKredit announces Annual Report 2025 (GlobeNewswire EN)
 
Today, 9 March 2026, KommuneKredit has published its Annual Report 2025....
09.03.26 - 13:48
DIRECTOR / PDMR NOTIFICATION (GlobeNewswire EN)
 
OCTOPUS AIM VCT 2 PLC...
09.03.26 - 13:46
Genius Group announces 2025 Financial Results with 80% Pro Forma Revenue Growth to $13.6 Million (GlobeNewswire EN)
 
Company completes transformation into a triple-engine AI education group preparing the World for the future of work: Genius School, Genius Academy and Genius Resorts...
09.03.26 - 13:46
Mink Ventures Completes Drilling at Montcalm Ni Cu Co Project (GlobeNewswire EN)
 
Mink Ventures Completes Montcalm Drill Program...
09.03.26 - 13:46
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors (GlobeNewswire EN)
 
CHICAGO and FORT WORTH, Texas, March 09, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced the launch of an expanded research initiative evaluating combinations of its clinical-stage GSK-3β inhibitor elraglusib with emerging RAS-targeted therapies....
09.03.26 - 13:42
ISSUE OF EQUITY AND TOTAL VOTING RIGHTS (GlobeNewswire EN)
 
OCTOPUS AIM VCT 2 PLC...
09.03.26 - 13:39
NOAA Determines TMC USA′s Consolidated Deep-Seabed Mining Application is in Substantial Compliance (GlobeNewswire EN)
 
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world's largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that the National Oceanic and Atmospheric Administration (NOAA) has determined that the consolidated application submitted by the Company's subsidiary, The Metals Company USA LLC (“TMC USA”), for an exploration license and commercial recovery permit under the Deep Seabed Hard Mineral Resources Act (DSHMRA) is in substantial compliance with the requirements of the Act and its implementing regulations....
09.03.26 - 13:39
IP Strategy to Participate at the Canaccord Genuity 6th Annual Digital Assets Virtual Symposium (GlobeNewswire EN)
 
GIG HARBOR, Wash., March 09, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced that Justin Stiefel, Chief Executive Officer, and Phil Blows, Chief Investment Officer, will participate in a fireside chat at the Canaccord Genuity 6th Annual Digital Assets Virtual Symposium on Wednesday, March 11, 2026 at 12:00 PM Pacific Time / 3:00 PM Eastern Time. The Company will also host individual and small group investor meetings throughout the day....
09.03.26 - 13:33
Jet.AI Inc. Reports Full Year 2025 Financial Results (GlobeNewswire EN)
 
LAS VEGAS, March 09, 2026 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced financial results for the full year ended December 31, 2025. The Company had approximately $13.7 million of cash and no debt as of March 5th, 2026 (vs $1.8 million at year end 2025) and is Net Income positive for the full year 2025 ($4.6 million in 2025 vs -$12.7 million in 2024). In the first quarter of 2026, Jet.AI expects the completion of the third milestone of its Canadian data center joint venture - related to powered land at its 385 acre Manitoba site and continued progress in the Maritimes. The power study for our Moapa NV data center site is ongoing, and the flyExclusive transaction remains on track to close April 30th. The Company maintains strong access to capital through its $250 million shelf facility...
09.03.26 - 13:33
UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses (GlobeNewswire EN)
 
HONG KONG, March 09, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise focused on biotechnology and healthcare, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), has signed a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex-President Super Injection, in cooperation with Huajin China Investment Company(”Huajin China”), alongside the Board-approved divestiture of its non-core business....
09.03.26 - 13:33
SRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders (GlobeNewswire EN)
 
EventHorizonIQ, available now at https://eventhorizoniq.com/pricing, provides investors and risk professionals with institutional-grade cross-asset regime intelligence...
09.03.26 - 13:33
Hudson Technologies to Attend 38th Annual Roth Conference (GlobeNewswire EN)
 
WOODCLIFF LAKE, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning, and Refrigeration industry – and one of the nation's largest refrigerant reclaimers – today announced that Ken Gaglione, President and Chief Executive Officer and Brian Bertaux, Chief Financial Officer will attend the 38th Annual Roth Conference on Monday, March 23, 2026 at The Ritz-Carlton, Laguna Niguel in Dana Point, California. Messrs. Gaglione and Bertaux will be available for one-on-one meetings throughout the day....
09.03.26 - 13:33
Alico to Participate at 38th Annual Roth Conference (GlobeNewswire EN)
 
FORT MYERS, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company's President and Chief Executive Officer, will host one-on-one meetings with investors at the 38th Annual Roth Conference, taking place in Laguna Niguel, CA on March 22-24, 2026....
09.03.26 - 13:33
Founder Group Limited Secures US$4 million 25.4MW Utility-Scale Solar Contract under Malaysia′s CGPP Programme (GlobeNewswire EN)
 
KUALA LUMPUR, Malaysia, March 09, 2026 (GLOBE NEWSWIRE) -- Founder Group Limited (NASDAQ: FGL) (“Founder Group” or the “Company”), a regional clean energy expert in Malaysia, today announced that it has been awarded an approximately RM16 million (US$4.14 million) Engineering, Procurement, Construction, and Commissioning (EPCC) contract for a 25.40MW large‑scale solar (LSS) project in Malaysia....
09.03.26 - 13:33
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 (GlobeNewswire EN)
 
TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, today announced that the first clinical outcomes from the Level 1 post-market CAPTAIN trial comparing the safety and efficacy of the TULSA Procedure™ with robotic radical prostatectomy in men with localized prostate cancer are scheduled to be presented during the Late-Breaking and High-Impact session at the 41st Annual European Association of Urology (“EAU 2026”) Congress in London, UK on March 13, 2026 at 9:40 a.m. EDT (1:40 p.m. GMT)....
09.03.26 - 13:33
Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 (GlobeNewswire EN)
 
Company to hold a conference call at 8:00 a.m. ET Company to hold a conference call at 8:00 a.m. ET...
09.03.26 - 13:33
Powell Max Limited Successfully Repositions for Its Next Phase of Growth (GlobeNewswire EN)
 
Hong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (“Powell Max” or the “Company”), a financial communications services provider, is pleased to provide the following corporate update regarding its successful repositioning....
09.03.26 - 13:33
Prairie Operating Co. Announces Participation in Upcoming Conference (GlobeNewswire EN)
 
HOUSTON, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin – today announced that members of its senior management team will participate in the upcoming investor conference....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn jedoch die Kraft, die die menschliche Aktivität bestimmt, nicht die Vernunft ist, bleibt der Mensch unter dem Niveau seiner eigenen Möglichkeiten. - Robert Strange McNamara
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!